COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,155 Articles (22,703 medRxiv, 8,452 bioRxiv)

Most recent first Previous |  Page 352: Articles 3511-3520  | Next

No evidence for enhanced disease with polyclonal SARS-CoV-2 antibody in the ferret model.
Reed, D. S., McElroy, A., Barbeau, D., McMillen, C., Tilston-Lunel, N., Nambulli, S., Cottle, E., Gilliland, T., Rannulu, H., Lundy, J., Olsen, E., O'Malley, K., Xia, M., Hartman, A., Luke, T., Egland, K., Bausch, C., Wu, H., Sullivan, E., Klimstra, W., Duprex, P.
10.1101/2023.08.19.553970 — Posted: 2023-08-21
SARS-CoV-2 variants Omicron BA.4/5 and XBB.1.5 significantly escape T cell recognition in solid organ transplant recipients vaccinated against the ancestral strain
Halvorson, T., Ivison, S., Huang, Q., Ladua, G., Yotis, D. M., Mannar, D., Subramaniam, S., Ferreira, V. H., Kumar, D., Belga, S., PREVenT Study Group, , Levings, M.
10.1101/2023.08.14.23293991 — Posted: 2023-08-21
Acute renal injury in patients with COVID-19, in the critical care unit of a public hospital, Lima-Peru.
VENEGAS JUSTINIANO, J. Y., HURTADO ARESTEGUI, A., MUCHO VILCA, K.
10.1101/2023.08.20.23294334 — Posted: 2023-08-21
Offspring cardiometabolic outcomes and postnatal growth trajectories after exposure to maternal SARS-CoV-2 infection
Shook, L. L., Castro, V. M., Herzberg, E. M., Fourman, L. T., Kaimal, A. J., Perlis, R. H., Edlow, A. G.
10.1101/2023.08.16.23294170 — Posted: 2023-08-21
Cohort Profile: Prospective Cohort to Study the COVID-19 Immune Response in Retail Workers in Quebec, Canada (CISACOV)
Santerre, K., Theriault, M., Brousseau, N., Rochette, S., Pelletier, J., Gilbert, C., Masson, J.-F., Baz, M., Boudreau, D., Trottier, S.
10.1101/2023.08.18.23294172 — Posted: 2023-08-21
Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia
Dharan, N., Sasson, S., Ahlenstiel, G., Anderson, C., Bloch, M., Buckland, G., Hamad, N., Han, W. M., Kelleher, A., Long, G., Matthews, G., Mina, M., Papot, E., Petoumenos, K., Swaminathan, S., Withers, B., Yun, J., Polizzotto, M., CORIA Study Group
10.1101/2023.08.17.23293358 — Posted: 2023-08-21
Evaluating public health effects of risk-based travel policy for the COVID-19 epidemic in Scotland
McLachlan, I., Huntley, S., Leslie, K., Bishop, J., Redman, C., Yebra, G., Shaaban, S., Christofidis, N., Lycett, S., Holden, M. T. G., Robertson, D. L., Smith-Palmer, A., Hughes, J., Nickbakhsh, S.
10.1101/2023.08.20.23293987 — Posted: 2023-08-21
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses
Owens, K., Esmaeili-Wellman, S., Schiffer, J. T.
10.1101/2023.08.20.23294350 — Posted: 2023-08-21
SARS-CoV-2 antibody response among COVID-19 patients is not affected by parasite co-infection
Gebrecherkos, T., Kebede, Y., Challa, F., Gebreegzabher, A., Abdella, S., Leta, D., Desta, A., Hailu, A., Tasew, G., Abdulkadir, M., Tessema, M., Tollera, G., Gessesse, Z., DF Schallig, H. H., Urban, B. C., Rinke de Wit, T., Welday, D.
10.1101/2023.08.20.23294345 — Posted: 2023-08-21
Emergence of neutralizing antibodies associates with clearance of SARS-CoV-2 during HIV-mediated immunosuppression
Karim, F., Bernstein, M., Zesuliwe, Z., Lustig, G., Upton, J.-L., Ganga, Y., Khan, K., Reedoy, K., Mazibuko, M., Govender, K., Thambu, K., Ngcobo, N., Venter, E., Makhado, Z., Hanekom, W., von Gottberg, A., Abdool Karim, Q., S. Adbool Karim, S., Manickchund, N., Magula, N., Gosnell, B., Moore, P. L., Lessells, R., de Oliveira, T., Moosa, Y., Sigal, A.
10.1101/2023.08.18.23293746 — Posted: 2023-08-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).